IDEAYA – Talk Bio

Actionable Insights Powered by AI

IDEAYA Advances Cancer Pipeline with Biocytogen’s Bispecific ADC, Targeting B7H3/PTK7

5 months ago talkbio0Tagged B7H3/PTK7, Biocytogen, bispecific ADC, cancer pipeline, IDEAYA, Precision Medicine, therapeutic autologous dendritic cells

IDEAYA, Biocytogen, Bispecific ADC, B7H3/PTK7, Cancer Pipeline, Precision Medicine Oncology

IDEAYA Secures $400M Option Deal with Biocytogen for Bispecific ADC

9 months ago talkbio0Tagged Biocytogen, bispecific ADC, IDEAYA, Malignant Neoplasms, therapeutic autologous dendritic cells

IDEAYA Biosciences, Biocytogen, Bispecific ADC, Option Deal, Cancer Treatment